Clear Labs, a Menlo Park, CA-based food safety company, closed $21m in Series B2 funding.
The round, which brought total funding to $45M, was led by Menlo Ventures, with participation from Wing VC, Dentsu Ventures, Felicis, and Khosla, along with a number of food production companies.
The company intends to use the funds to ramp up its commercial operations and build new features for Clear Safety, its flagship product for food safety testing.
Led by Sasan Amini, CEO, Clear Labs provides Clear Safety, a platform built for food safety testing, which combines Next-Gen Sequencing, advanced microbiology, robotic automation, data science, and software analytics. The system collects hundreds of millions of data points per analysis that can be used to learn everything about a pathogen in a single test. This data also serves as the foundation for new applications from predictive risk assessment to nutrigenomics to new product development.
Currently, the platform supports high-volume testing for Salmonella, with the expectation to add support for additional pathogens and software features in 2019.
Clear Labs has over 40 customers globally, including many of the leading food brands and service labs around the world.